Meril receives ICMR approval for indigenous Covid-19 Self-Test, CoviFind

Meril receives ICMR approval for indigenous Covid-19 Self-Test, CoviFind

FPJ BureauUpdated: Friday, June 18, 2021, 12:49 PM IST
article-image

Global medtech company Meril, based in Vapi, Gujarat, has announced its self-use Rapid Antigen Test for Covid-19, CoviFind, has received approval from the Indian Council of Medical Research (ICMR). This indigenously researched and developed test can detect the SARS-CoV-2 virus reliably in infectious individuals and can therefore be used for testing symptomatic individuals and immediate contacts of confirmed coronavirus cases as specified by recent ICMR guidelines.

Meril’s home-use rapid antigen tests will expand access to Covid-19 testing, while also helping the nation meet the demand for increased and frequent screening to curb the spread of Covid-19. The provision of high-quality rapid antigen testing will also enable access to screening in previously out-of-reach or under-equipped areas.

RECENT STORIES

Why the transition to Clean Energy in the Transportation Sector has become imperative

Why the transition to Clean Energy in the Transportation Sector has become imperative

Babus, mantris & buzz: Scindia to win with highest votes in MP!

Babus, mantris & buzz: Scindia to win with highest votes in MP!

Babus, mantris & buzz: Where is Raghav Chaddha?

Babus, mantris & buzz: Where is Raghav Chaddha?

USAID Launches WOHLA - Bridging Healthcare and Economic Gaps for Women in India

USAID Launches WOHLA - Bridging Healthcare and Economic Gaps for Women in India

THDCIL conferred with "The GEEF Global Environment Award 2024" in the Power Industry

THDCIL conferred with